Gastrin-releasing peptide receptor antagonism induces protection from lethal sepsis: Involvement of toll-like receptor 4 signaling

Molecular Medicine

Volumn 18, Issue 8, 2012, Pages 1209-1219

  Petronilho, Fabricia ^a,b   Vuolo, Francieli ^b   Galant, Letícia Selinger ^b   Constantino, Larissa ^b   Tomasi, Cristiane Damiani ^b   Giombelli, Vinicius Renne ^b   de Souza, Cláudio Teodoro ^a   da Silva, Sabrina ^a   Barbeiro, Denise Frediani ^c   Soriano, Francisco Garcia ^c   Streck, Emílio Luiz ^b   Ritter, Cristiane ^b   Zanotto Filho, Alfeu ^d   Pasquali, Matheus Augusto ^d   Gelain, Daniel Pens ^d   Rybarczyk Filho, José Luiz ^d   Moreira, José Cláudio Fonseca ^d   Block, Norman L ^e   Roesler, Rafael ^d,f   Schwartsmann, Gilberto ^d,e   Schally, Andrew V ^e   Dal Pizzol, Felipe ^b   more..

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^b UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f National Institute for Translational Medicine   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN RELEASING PEPTIDE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; RC 3095; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SEPSIS; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; ANIMALS; BOMBESIN; CELL MOVEMENT; CELL NUCLEUS; CHEMOKINES; DISEASE MODELS, ANIMAL; FEMALE; GASTRIN-RELEASING PEPTIDE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES; MALE; MICE; MIDDLE AGED; MODELS, BIOLOGICAL; PEPTIDE FRAGMENTS; RATS; RECEPTORS, BOMBESIN; RNA, MESSENGER; SEPSIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

EID: 84870336694     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2012.00083     Document Type: Article

References (52)

1. Hotchkiss RS, Karl IE. (2003) The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348:138-50.
2. Riedemann NC, Guo RF, Ward PA. (2003) Novel strategies for the treatment of sepsis. Nat. Med. 9:517-24.
3. Abraham E. (2003) Neutrophils and acute lung injury. Crit. Care Med. 31:195-9.
4. Hedge A, Zhang H, Moochhala SM, Bhatia M. (2007) Neurokinin-1 receptor antagonist treatment protects mice against lung injury in polymicrobial sepsis. J. Leukoc. Biol. 82:678-85.
5. Chishti AD, Shenton K, Kirby JA, Baudouin SV. (2004) Neutrophil chemotaxis and receptor expression in clinical septic shock. Intensive Care Med. 30:605-11.
6. Alves-Filho JC, et al. (2009) Regulation of chemokine receptor by toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc. Natl. Acad. Sci. U. S. A. 106:4018-23.
7. Secher T, et al. (2009) Crucial role of TNF receptors 1 and 2 in the control of polymicrobial sepsis. J. Immunol. 182:7855-64.
8. Sugiyama K, Muroi M, Tanamoto K. (2008) A novel TLR4-binding peptide that inhibits LPS induced activation of NF-KappaB and vivo toxicity. Eur. J. Pharmacol. 10:152-6.
9. Tsung A, et al. (2007) A novel inhibitory peptide of toll-like receptor signaling limits lipopolysaccharide-induced production of inflammatory mediators and enhances survival in mice. Shock. 27:364-9.
10. Hellmich MR, Ives KL, Udupi V. (1999) Multiple protein kinase pathways are involved in gastrinreleasing peptide receptor-regulated secretion. J. Biol. Chem. 274:23901-9.
11. Alves-Filho JC, de Freitas A, Russo M, Cunha FQ. (2006) Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit. Care Med. 34:461-70.
12. Anastasi A, Erspamer V, Bucci M. (1971) Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia. 27:166-7.
13. Subramaniam M, et al. (2003) Bombesin-like peptides and mast cell responses: relevance to bronchopulmonary dysplasia? Am. J. Respir. Crit. Care Med. 168:601-11.
14. Grimsholm O, Rantapaa-Dahlqvist S, Forsgren S. (2005) Levels of gastrin releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. Arthritis Res. Ther. 7:R416-26.
15. Cornelio DB, Dal-Pizzol F, Roesler R, Schwartsmann G. (2007) Targeting the bombesin/gastrinreleasing peptide receptor to treat sepsis. Recent Pat. Antiinfect. Drug Discov. 2:178-81.
16. Jensen RT, Battey JF, Spindel ER, Benya RV. (2008) International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol. Rev. 60:1-42.
17. Roesler R, Henriques JA, Schwartsmann G. (2006) Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disorders. C.N.S. Neurol. Disord. Drug Targets. 5:197-204.
18. Schally AV. (2008) New approaches to the therapy of various tumors based on peptide analogues. Horm. Metab. Res. 40:315-22.
19. Genton L, Kudsk KA. (2003) Interactions between the enteric nervous system and the immune system: role of neuropeptides and nutrition. Am. J. Surg. 186:253-8.
20. Schwartsmann G, et al. (2006) A phase I trial of the bombesin/gastrin-releasing peptide (BN/ GRP) antagonist RC3095 in patients with advanced solid malignancies. Invest New Drugs. 24:403-12.
21. Guha M, Mackman N. (2001) LPS induction of gene expression in human monocytes. Cell Signal. 13:85-94.
22. Dal-Pizzol F, et al. (2006) Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis. Am. J. Respir. Crit. Care Med. 173:84-90.
23. Ishii KJ, Akira S. (2004) Toll-like receptors and sepsis. Curr. Infect. Dis Rep. 6:361-6.
24. Ritter C, et al. (2004) Treatment with Nacetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit. Care. 32:342-9.
25. Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Research, Division on Earth and Life Studies, National Research Council of the National Academies. (2011) Guide for the Care and Use of Laboratory Animals. 8th edition. Washington (DC): National Academies Press. [cited 2012 Oct 12]. Available from: http://oacu.od.nih.gov/regs/
26. Bone RC, Sibbald WJ, Sprung CL. (1992) The ACCP-SCCM consensus conference on sepsis and organ failure. Chest. 101:1481-3.
27. Radulovic S, et al. (1991) Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with Nterminal d-Trp or d-Tpi. Int. J. Pept. Protein Res. 38:593-600.
28. Kuhn M, von Mering C, Campillos M, Jensen LJ, Bork P. (2008). STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res. 36:D684-8.
29. Kuhn M, et al. (2010) STITCH 2: an interaction network database for small molecules and proteins. Nucleic Acids Res. 38:D552-6.
30. Chang W, Alvarez-Gonzalez R. (2001) The sequence-specific DNA binding of NF-αB is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase I. J. Biol. Chem. 276:47664-70.
31. Bradford MM. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal. Biochem. 72:248-54.
32. Laemmli UK. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-5.
33. De Souza CT, et al. (2003) Peroxisome proliferatoractivated receptor gamma coactivator-1-dependent uncoupling protein-2 expression in pancreatic islets of rats: a novel pathway for neural control of insulin secretion. Diabetologia. 46:1522-31.
34. Benjamim CF, Ferreira SH, Cunha FQ. (2000) Role of nitric oxide in the failure of neutrophil migration in sepsis. J. Infect. Dis. 182:214-23.
35. Godshall CJ, et al. (2002) Genetic background determines susceptibility during murine septic peritonitis. J. Surg. Res. 102:45-9.
36. Gonzalez-Rey E, Delgado M. (2007) Antiinflammatory neuropeptide receptors: new therapeutic targets for immune disorders? Trends Pharmacol. Sci. 28:482-91.
37. Alves-Filho JC, et al. (2008) The role of neutrophils in severe sepsis. Shock. 30(Suppl 1):3-9.
38. Annane D, Bellissant E, Cavaillon JM. (2005) Septic shock. Lancet 365:63-78.
39. Williams DL, et al. (2003) Modulation of tissue toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit. Care Med. 31:1808-18.
40. Brogden KA, Guthmiller JM, Salzet M, Zasloff M. (2005) The nervous system and innate immunity: the neuropeptide connection. Nat. Immunol. 6:558-64.
41. Tsatsanis C, et al. (2006) Corticotropin releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1. J. Immunol. 176:1869-77.
42. Taylor AW. (2005) The immunomodulating neuropeptide alpha-melanocytestimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages. J. Neuroimmunol. 162:43-50.
43. Genton L, Kudsk KA. (2003) Interactions between the enteric nervous system and the immune system: role of neuropeptides and nutrition. Am. J. Surg. 186:253-8.
44. Dal-Pizzol F. (2004) Alternative activated macrophage: a new key for systemic inflammatory response syndrome and sepsis treatment? Crit. Care Med. 32:1971-2.
45. Degan S, Lopez GY, Kevill K, Sunday ME. (2008) Gastrin-releasing peptide, immune responses, and lung disease. Ann. N. Y. Acad. Sci. 1144:136-47.
46. Kerfoot SM, Kubes P. (2005) Local coordination verses systemic deregulation: complexities in leukocyte recruitment revealed by local and systemic activation of TLR4 in vivo. J. Leukoc. Biol. 77:862-7.
47. Andonegui G, et al. (2003) Endothelium-derived toll-like receptor-4 is the key molecule in LPSinduced neutrophil sequestration into lungs. J. Clin. Invest. 111:1011-20.
48. Salomao R, et al. (2009). Toll-like receptor pathway signaling is differently regulated in neutrophils and peripheral mononuclear cells of patients with sepsis, severe sepsis, and septic shock. Crit. Care Med. 37:132-9.
49. Dickerson C, Undem B, Bullock B, Winchurch RA. (1998) Neuropeptide regulation of proinflammatory cytokine responses. J. Leukoc. Biol. 63:602-5.
50. Arranz A, et al. (2008) Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide. Mol. Immunol. 45:2970-80.
51. Petronilho F, Roesler R, Schwartsmann G, Dal Pizzol F. (2007) Gastrin-releasing peptide receptor as a molecular target for inflammatory diseases. Inflamm. Allergy Drug Targets. 6:197-206.
52. Czepielewski RS, et al. (2012) Gastrin-releasing peptide receptor (GRPR) mediates chemotaxis in neutrophils. Proc. Natl. Acad. Sci. U. S. A. 109:547-52.